Modeling the Impact of Simulated Educational Interventions on the Use and Abuse of Pharmaceutical Opioids in the United States
Wayne Wakeland(Portland State University), J. David Haddox(Purdue Pharma (United States)), Lynn R. Webster(Adherent Technologies (United States)), Dennis McCarty(Oregon Health & Science University), John FitzGerald(Purdue Pharma (United States)), Teresa Schmidt(Portland State University), Alexandra Nielsen(Portland State University)
Cited by 44
Related Papers
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Risk Factors for Opioid-Use Disorder and Overdose
|Anesthesia & Analgesia|2017|504
Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain
|New England Journal of Medicine|2014|331
Sleep-Disordered Breathing and Chronic Opioid Therapy
|Pain Medicine|2007|309
A Randomized, Double-Blind, Placebo-Controlled Study of Intrathecal Ziconotide in Adults with Severe Chronic Pain
|Journal of Pain and Symptom Management|2006|304